Skip to main content
  • Home
  •  TAVI Head-To-Head: Design, Data and Directions for Clinical Practice

TAVI Head-To-Head: Design, Data and Directions for Clinical Practice

Topic:
  • Intervention

Available Credit:

  • 1.00 EBAC

Course Published On:

Course Expiry Date:

TAVI Head-To-Head: Design, Data and Directions for Clinical Practice
No ratings

Overview

In this on-demand version of the live broadcast, chaired by Dr Martin Swaans (St Antonius Hospital, NL), faculty explore the evolving data for transcatheter aortic valve implantation (TAVI) and why we need to improve triaging practices towards the most appropriate interventions.

Leading experts, Prof Sabine Bleiziffer (Heart and Diabetes Center NRW, DE), Prof Vijay Kunadian (Newcastle University, UK) and Dr Marta Sitges (Hospital Clínic de Barcelona, ES), discuss valve design and durability, clinical data from the SMART trial presented at ACC 2024 and how we can provide greater access for women in TAVI.

Support Statement

This programme is supported by an unrestricted educational grant from Medtronic.

Disclosure

In compliance with EBAC guidelines, all speakers/chairpersons participating in this programme have disclosed or indicated potential conflicts of interest which might cause a bias in the presentations. The Organising Committee/Course Director is responsible for ensuring that all potential conflicts of interest relevant to the event are declared to the audience prior to the CME activities.

Terms & Conditions

Radcliffe Medical Education requires contributors to our CME programmes to disclose any relevant financial relationships that have occurred within the past 12 months that could create a conflict of interest. These will be identified in the faculty section if applicable.
 

The session, ‘TAVI Head-To-Head: Design, Data and Directions for Clinical Practice’ is accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC) for 1 hour of external CME credits. 
 

Each participant should claim only those hours of credit that have actually been spent in the educational activity. EBAC works according to the quality standards of the European Accreditation Council for Continuing Medical Education (EACCME), which is an institution of the European Union of Medical Specialists (UEMS).
 

Through an agreement between the European Board for Accreditation of Continuing Education for Health Professionals and the American Medical Association, physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™. Information on the process to convert EBAC credit to AMA credit can be found on the AMA website.

Instruction to Participants

There is no fee for taking part in this online learning activity.
 

Activities are designed to be completed within 60 minutes and must be completed by the registered user. Physicians should only claim credits for time spent on the activity. To successfully earn credit, participants must complete the activity in full in the indicated time frame.
 

To complete the course and claim certification participants must:
 

  • Read the course outline information supplied and complete pre-test questions if supplied prior to starting the activity. Users must read and study the activity in its entirety before completing the post-test questions.
  • Your results will be automatically saved and if a pass score is achieved (where applicable), you may be eligible to claim credit for the activity and receive a certificate of completion.

 

Target Audience

  • General Cardiologists
  • Echocardiographers
  • Physiologists
  • Physicians referring patients for TAVI
  • Interventional Cardiologists
  • Cardiac Surgeons

Learning Objectives

  • Recall TAVI SMART trial data and the implications on clinical practice
  • Describe novel valve designs and the impact on long-term performance
  • Develop an expert-led approach to improving equitable access to TAVI
Register now Log in

Module

Title

Duration

Speakers

1 Introduction 3m 43s Martin Swaans
2 TAVI: Current Status and Valve Durability 16m 1s Marta Sitges
3 Data from the ACC 2024 12m 18s Sabine Bleiziffer
4 Improving Access 16m 19s Vijay Kunadian
5 Panel Discussion and Audience Q&A 12m 6s Martin Swaans Marta Sitges Sabine Bleiziffer Vijay Kunadian
1.

Introduction

Duration: 3m 43s

Speakers: Martin Swaans

2.

TAVI: Current Status and Valve Durability

Duration: 16m 1s

Speakers: Marta Sitges

3.

Data from the ACC 2024

Duration: 12m 18s

Speakers: Sabine Bleiziffer

4.

Improving Access

Duration: 16m 19s

Speakers: Vijay Kunadian

5.

Panel Discussion and Audience Q&A

Duration: 12m 6s

Speakers: Martin Swaans Marta Sitges Sabine Bleiziffer Vijay Kunadian

Course Director

Martin Swaans

Martin Swaans

Department of Cardiology, St Antonius Hospital, Nieuwegein

Dr Martin Swaans is cardiologist at St Antonius Hospital Nieuwegein in the Netherlands. Dr Swaans specialises in cardiac imaging, particularly in electrophysiology and interventional procedures.

View full profile

Speaker

Marta Sitges

Hospital Clinic, University of Barcelona

Prof Marta Sitges is a senior consultant non-invasive cardiologist at the Cardiovascular Institute in Hospital Clinic and Professor of Medicine at the University of Barcelona.

View full profile

Sabine Bleiziffer

Heart and Diabetes Center NRW, Bad Oeynhausen, DE

Prof Sabine Bleiziffer is a Senior Consultant Cardiac Surgeon at Heart and Diabetes Center NRW, Bad Oeynhausen, DE.

She graduated from the University of Leipzig and the Ludwig Maximilian University in Munich, Germany.

Prof Bleiziffer focuses on structural valve diseases.

View full profile

Vijay Kunadian

Newcastle University, Newcastle-Upon-Tyne, UK

Prof Vijay Kunadian is Personal Chair and Professor of Interventional Cardiology at Newcastle University. 

View full profile
1.00 EBAC

TAVI Head-To-Head: Design, Data and Directions for Clinical Practice has been accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC) for one CME point.

Related Courses

TAVI – Is Lifetime Patient Management the Alpha to Omega of Contemporary Practice?
  • 1.00 EBAC

Learning objectives

  • Evaluate the factors influencing coronary access in different valve designs
  • Formulate strategies to optimise coronary access based on valve characteristics
  • Evaluate the role of valve design in reducing pacemaker implantation rates and enhancing future coronary access
  • Learn the step-by-step process for achieving optimum implant depth during TAVI
  • Apply guidelines and best practices for achieving and confirming optimum implant depth in TAVI procedures
See more
Getting it Right First Time in Severe Aortic Stenosis - Key Insights for Long Term Success
  • 1.00 EBAC

Learning objectives

  • Recall current and predicted trends in TAVI with respect to preserving coronary access
  • Consider determining factors for choosing valves in low risk populations
  • Discuss solutions for maximising valve durability and haemodynamics and for treating degenerated TAVI
See more
TIO 2023 – Debates
  • 1.00 EBAC

Learning objectives

  • Compare the utility of repair and replacement valve technology in mitral regurgitation
  • Individualise valve choice for aortic regurgitation based on valve durability and patient features
  • Recall the utility and limitations of specialty balloons
  • Evaluate emerging approaches to the treatment of complex left main and other coronary bifurcation lesions
  • Discuss the impact of PCI on top of optimal medical therapy in ischaemic left ventricular systolic dysfunction
  • Identify suitable patients for interatrial shunting
  • Discuss the merits of alternative antiplatelet strategies to DAPT in ACS and CCS following PCI
See more
TIO 2023 – Debates & Controversies – Live Cases & Discussions
  • 1.00 EBAC

Learning objectives

  • Compare the utility of repair and replacement valve technology in mitral regurgitation
  • Individualise valve choice for aortic regurgitation based on valve durability and patient features
  • Recall the utility and limitations of specialty balloons
  • Evaluate emerging approaches to the treatment of complex left main and other coronary bifurcation lesions
  • Discuss the impact of PCI on top of optimal medical therapy in ischaemic left ventricular systolic dysfunction
  • Identify suitable patients for interatrial shunting
See more
TIO 2023 – Keynote & Debate
  • 1.00 EBAC

Learning objectives

  • Compare the utility of repair and replacement valve technology in mitral regurgitation
  • Individualise valve choice for aortic regurgitation based on valve durability and patient features
  • Recall the utility and limitations of specialty balloons
  • Evaluate emerging approaches to the treatment of complex left main and other coronary bifurcation lesions
  • Discuss the impact of PCI on top of optimal medical therapy in ischaemic left ventricular systolic dysfunction
  • Identify suitable patients for interatrial shunting
See more
TIO 2023 – Left Main & Bifurcations – Live Cases & Discussions
  • 1.00 EBAC

Learning objectives

  • Compare the utility of repair and replacement valve technology in mitral regurgitation
  • Individualise valve choice for aortic regurgitation based on valve durability and patient features
  • Recall the utility and limitations of specialty balloons
  • Evaluate emerging approaches to the treatment of complex left main and other coronary bifurcation lesions
  • Discuss the impact of PCI on top of optimal medical therapy in ischaemic left ventricular systolic dysfunction
  • Identify suitable patients for interatrial shunting
  • Discuss the merits of alternative antiplatelet strategies to DAPT in ACS and CCS following PCI
See more
TIO 2023 – Left Main & Bifurcations
  • 1.00 EBAC

Learning objectives

  • Compare the utility of repair and replacement valve technology in mitral regurgitation
  • Individualise valve choice for aortic regurgitation based on valve durability and patient features
  • Recall the utility and limitations of specialty balloons
  • Evaluate emerging approaches to the treatment of complex left main and other coronary bifurcation lesions
  • Discuss the impact of PCI on top of optimal medical therapy in ischaemic left ventricular systolic dysfunction
  • Identify suitable patients for interatrial shunting
  • Discuss the merits of alternative antiplatelet strategies to DAPT in ACS and CCS following PCI
See more
TIO 2023 – Balloon Revolution – Live Cases & Discussions
  • 1.00 EBAC

Learning objectives

  • Compare the utility of repair and replacement valve technology in mitral regurgitation
  • Individualise valve choice for aortic regurgitation based on valve durability and patient features
  • Recall the utility and limitations of specialty balloons
  • Evaluate emerging approaches to the treatment of complex left main and other coronary bifurcation lesions
  • Discuss the impact of PCI on top of optimal medical therapy in ischaemic left ventricular systolic dysfunction
  • Identify suitable patients for interatrial shunting
  • Discuss the merits of alternative antiplatelet strategies to DAPT in ACS and CCS following PCI
See more
TIO 2023 – Balloon Revolution
  • 1.00 EBAC

Learning objectives

  • Compare the utility of repair and replacement valve technology in mitral regurgitation
  • Individualise valve choice for aortic regurgitation based on valve durability and patient features
  • Recall the utility and limitations of specialty balloons
  • Evaluate emerging approaches to the treatment of complex left main and other coronary bifurcation lesions
  • Discuss the impact of PCI on top of optimal medical therapy in ischaemic left ventricular systolic dysfunction
  • Identify suitable patients for interatrial shunting
  • Discuss the merits of alternative antiplatelet strategies to DAPT in ACS and CCS following PCI
See more
TIO 2023 – Key Issues in TAVI - Live Cases and Discussions
  • 1.00 EBAC

Learning objectives

  • Compare the utility of repair and replacement valve technology in mitral regurgitation
  • Individualise valve choice for aortic regurgitation based on valve durability and patient features
  • Recall the utility and limitations of specialty balloons
  • Evaluate emerging approaches to the treatment of complex left main and other coronary bifurcation lesions
  • Discuss the impact of PCI on top of optimal medical therapy in ischaemic left ventricular systolic dysfunction
  • Identify suitable patients for interatrial shunting
  • Discuss the merits of alternative antiplatelet strategies to DAPT in ACS and CCS following PCI
See more